Degenerative Disorders

  • Gerald S. Golden
Part of the Topics in Pediatrics book series (TIPE)


The hallmark of degenerative disorders of the nervous system is the progressive loss of previously acquired abilities. In young children, deceleration in the rate of development is often the first sign of degeneration. The patient falls progressively behind other children, and subsequently there is actual loss of previously acquired achievements. This is quantitated as a declining developmental quotient. By definition, this deterioration is not due to an exogenous agent or event, or to secondary involvement of the nervous system by a generalized systemic disease. Most of the degenerative disorders are hereditary, although the biochemical basis of many of these conditions is not fully understood.


Biliary Atresia Optic Atrophy Degenerative Disorder Neuronal Ceroid Lipofuscinosis Developmental Quotient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Farrell, D. F., and Ochs, U., 1981, Gm, gangliosidosis: Phenotypic variation in a single family, Ann. Neurol. 9: 225–231.PubMedCrossRefGoogle Scholar
  2. 2.
    Farrell, D. F., and MacMartin, M. P., 1981, GM, gangliosidosis: Enzymatic variation in a single family, Ann. Neurol. 9: 232–286.PubMedCrossRefGoogle Scholar
  3. 3.
    Miloy, C. E., Gilbert, E. F., France, T. D., O’Brien, J. F., and Chun, R. W. M., 1978, Clinical and extrancural histologic diagnosis of neuronal ceroid-lipofuscinosis, Neurology 28: 1008–1012.Google Scholar
  4. 4.
    Martin, J. J., Centerick, C., and Libert, J., 1980, Skin and conjunctival nerve biopsies in adrenoleukodystrophy and its variants, Ann. Neurol. 8: 291–295.PubMedCrossRefGoogle Scholar
  5. 5.
    Moser, H. W., Moser, A. E., Trojak, J. E., and Supplee, S. W., 1983, Identification of female carriers of adrenoleukodystrophy, J. Pediatr. 103: 54–59.PubMedCrossRefGoogle Scholar
  6. 6.
    Moser, H. W., Moser, A. E., Singh, I., and O’Neill, B. P., 1984, Adrenoleukodystrophy: Survey of 303 cases: Biochemistry, diagnosis, and therapy, Ann. Neurol. 16: 628–641.PubMedCrossRefGoogle Scholar
  7. 7.
    von Specht, B. U., Geiger, B., Arnon, R., Passwell, J., Keren, G., Goldman, B., and Padeh, B., 1979, Enzyme replacement in Tay—Sachs disease, Neurology 28: 848–854.Google Scholar

Additional Reading

  1. Dyken, P., and Krawiecki, N., 1983, Neurodegencrative diseases of infancy and childhood, Ann. Neurol. 13: 351–364.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1987

Authors and Affiliations

  • Gerald S. Golden
    • 1
  1. 1.Department of Neurology, The Health Science CenterUniversity of Tennessee, MemphisMemphisUSA

Personalised recommendations